Schedule a Free Evaluation: 919-354-3775 contact@extivita.org
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Vimeo
  • Linkedin
  • YouTube
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Vimeo
  • Linkedin
  • YouTube
  • Patient Portal
  • Register
  • Contact
Extivita - Hyperbaric Oxygen Therapy - Durham, NC
  • Home
  • Conditions We Treat
  • Therapies
    • Hyperbaric Oxygen
    • IV Therapy
    • Neurofeedback
    • PEMF
    • Supplements
    • Longevity Challenge
  • Testimonials
  • About
    • News
    • Research
    • Extivita RTP Team
Select Page

Hyperbaric oxygen therapy for choroidal neovascularization: a pilot study.

by Extivita | Jun 23, 2015 | Macular Degeneration

Abstract: Choroidal neovascularization (CNV) is one of the leading causes of blindness worldwide and affects patients with wet age-related macular degeneration (AMD). Its natural course may lead to impaired central vision and macular fibrosis. Even VEGF blockade,...

Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.

by Extivita | Aug 26, 2014 | Cancer

Abstract: This work provides a systematic review of the literature from January 2003 to April 2014 pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the jaw (ONJ), and offers recommendations for its management based on...

Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.

by Extivita | Aug 26, 2014 | Chronic Wounds

Abstract: This work provides a systematic review of the literature from January 2003 to April 2014 pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the jaw (ONJ), and offers recommendations for its management based on...

Sequential therapy with belimumab followed by rituximab in Sjögren’s syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.

by Extivita | Dec 21, 2013 | Lymphoma

Abstract: The overexpression of B-cell activating factor (BAFF) in mucosa-associated lymphoid tissue (MALT) may decrease the efficacy of rituximab treatment in Sjögren’s syndrome (SS). Anti-CD20 therapy was effective on marginal zone B cells, in the murine model...

Refractory postsurgical pyoderma gangrenosum in a patient with Beckwith Wiedemann syndrome: response to multimodal therapy.

by Extivita | Oct 25, 2013 | Burns

Abstract: Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that may be difficult to diagnose and treat. We presented a 41-year-old woman who required skin grafting following third-degree burns to her left breast. She suffered recurrent graft dehiscence and...
« Older Entries

Search News

 

Archives

 

Contact Us

     

     

     

     

    Professional Memberships

    HBOT Member Logo
    • About Extivita
    • Extivita RTP Team
    • Patient Portal
    • Register
    • Contact
    • Policies
    • Facebook
    • Twitter
    • Instagram
    • RSS
    © 2015-2021 Extivita, LLC
    Hyperbaric Oxygen Therapy (HBOT), Nutritional IV, Neurofeedback Clinic located in Research Triangle Park, North Carolina (RTP, Raleigh, Durham, Chapel Hill).